Rebound effect of hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism
Journal of Endocrinological Investigation · 2024
DOI: 10.1007/s40618-024-02480-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von T Piticchio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy. tommaso.pi…. Hauptthemen laut MEDLINE: Hypothyroidism, Thyrotropin, Hypothalamo-Hypophyseal System, Thyroxine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Hypothalamic-pituitary thyrotropic activity (HPta) is crucial since TSH is the mainstay for evaluating primary hypothyroidism (hT) and replacement therapy in clinical practice. Despite TSH values, some patients experience symptoms and metabolic alterations, raising several issues about hT. The aim of the study was to investigate factors influencing the TSH values achieved after a period of hT induced in a standardized and controlled manner (TSH_time1).
Methods
Our institutional database was searched to extract records of differentiated thyroid cancer (DTC) patients undergoing a LT4 withdrawal protocol prior to radioiodine (RAI) administration. We collected clinical and biochemical parameters before LT4 discontinuation and after one month of induced hT. We performed Mann-Whitney U-test and linear regression analyses.
Results
We included 102 patients, with a median age of 44 years. In univariate analyses, TSH_time1 was correlated with age (p 0.005) and the dose pro Kg/die of LT4 assumed until the discontinuation of LT4 (LT4_dose) (p 0.023). The higher the age, the lower the TSH_time1 level. The higher the LT4_dose, the higher the TSH_time1 level. After multivariate analysis, the fittest model included age, BMI, LT4_dose, and systemic inflammation response index with an adjusted R 2 of 0.4.
Conclusion
The study highlights new mechanisms that influence HPta. HPta progressively reduces with age, and this must be considered when evaluating TSH values in the elderly. Furthermore, we report for the first time a rebound effect of HPta, determined by the dose pro Kg/die of LT4 taken prior to its discontinuation. Inflammation and metabolic status also affect these phenomena.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy. tommaso.piticchio@phd.unict.it.
- Department of Medicine and Surgery, University of Enna "Kore", Enna, Italy. tommaso.piticchio@phd.unict.it.
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy.
- Clinic for Endocrinology and Diabetology, Lugano Regional Hospital, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
- Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.
- Department of Public Health, University of Naples Federico II, Naples, Italy.
Zitieren
APA
Piticchio, T., Luongo, C., Trimboli, P., Salvatore, D., & Frasca, F. (2024). Rebound effect of hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02480-6
Vancouver
Piticchio T, Luongo C, Trimboli P, Salvatore D, Frasca F. Rebound effect of hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism. Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02480-6
BibTeX
@article{Piticchio2024,
author = {Piticchio, T and Luongo, C and Trimboli, P and Salvatore, D and Frasca, F},
title = {Rebound effect of hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism},
journal = {Journal of Endocrinological Investigation},
year = {2024},
doi = {10.1007/s40618-024-02480-6}
}
EUVIMED